What does the Oxbryta settlement calculator estimate?
It estimates potential compensation for patients or families of patients who suffered serious complications — including stroke, death, or disease progression — potentially related to Oxbryta (voxelotor) use.
Why was Oxbryta recalled?
Pfizer voluntarily recalled Oxbryta globally in September 2024 after post-marketing data suggested patients on voxelotor may have had higher rates of vaso-occlusive crises and death compared to those not on the drug.
Who may qualify for an Oxbryta lawsuit?
Sickle cell disease patients who used Oxbryta and suffered a stroke, severe vaso-occlusive crisis, or death, and their surviving family members, may have potential claims.
Is there an active Oxbryta MDL or class action?
Oxbryta litigation is still forming as of 2026. Individual product liability claims are being filed against Pfizer in various jurisdictions. No consolidated MDL has been officially formed yet.
How accurate is the Oxbryta settlement calculator?
This calculator provides an educational estimate only. Oxbryta litigation is early-stage and no settlement benchmarks have been established. An attorney can provide a more specific case evaluation.
